Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells

Biomolecular Pathogenesis of Borderline Ovarian Tumors: Focusing Target Discovery Through Proteogenomics

(2010) D. Vergara et al.   CURRENT CANCER DRUG TARGETS

Epigenetics of ovarian cancer: From the lab to the clinic

(2010) Reza Asadollahi et al.   GYNECOLOGIC ONCOLOGY

Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin

(2010) J-C Cheng et al.   ONCOGENE

Minireview: Epigenetic Changes in Ovarian Cancer

(2009) Curt Balch et al.   ENDOCRINOLOGY

Laminin-1 induces E-cadherin expression in 3-dimensional cultured breast cancer cells by inhibiting DNA methyltransferase 1 and reversing promoter methylation status

(2009) Gabriel Benton et al.   FASEB JOURNAL

Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression

(2008) Laurie G. Hudson et al.   CLINICAL & EXPERIMENTAL METASTASIS

Epigenetic Regulation of E-Cadherin Controls Endometrial Receptivity

(2008) Fahimeh Rahnama et al.   ENDOCRINOLOGY

Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer

(2008) A. Astanehe et al.   JOURNAL OF CELL SCIENCE

Metastasis and AKT activation

(2008) Shijie Sheng et al.   JOURNAL OF CELLULAR PHYSIOLOGY